1. Home
  2. IDYA vs FBK Comparison

IDYA vs FBK Comparison

Compare IDYA & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • FBK
  • Stock Information
  • Founded
  • IDYA 2015
  • FBK 1906
  • Country
  • IDYA United States
  • FBK United States
  • Employees
  • IDYA N/A
  • FBK N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • FBK Major Banks
  • Sector
  • IDYA Health Care
  • FBK Finance
  • Exchange
  • IDYA Nasdaq
  • FBK Nasdaq
  • Market Cap
  • IDYA 2.3B
  • FBK 2.1B
  • IPO Year
  • IDYA 2019
  • FBK 2016
  • Fundamental
  • Price
  • IDYA $26.88
  • FBK $59.16
  • Analyst Decision
  • IDYA Buy
  • FBK Buy
  • Analyst Count
  • IDYA 15
  • FBK 5
  • Target Price
  • IDYA $47.92
  • FBK $59.00
  • AVG Volume (30 Days)
  • IDYA 1.2M
  • FBK 438.4K
  • Earning Date
  • IDYA 11-03-2025
  • FBK 10-14-2025
  • Dividend Yield
  • IDYA N/A
  • FBK 1.28%
  • EPS Growth
  • IDYA N/A
  • FBK N/A
  • EPS
  • IDYA N/A
  • FBK 1.94
  • Revenue
  • IDYA $7,000,000.00
  • FBK $410,807,000.00
  • Revenue This Year
  • IDYA $63.41
  • FBK $34.11
  • Revenue Next Year
  • IDYA $305.49
  • FBK $22.63
  • P/E Ratio
  • IDYA N/A
  • FBK $30.51
  • Revenue Growth
  • IDYA N/A
  • FBK N/A
  • 52 Week Low
  • IDYA $13.45
  • FBK $38.83
  • 52 Week High
  • IDYA $32.67
  • FBK $60.52
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 59.69
  • FBK 75.52
  • Support Level
  • IDYA $26.77
  • FBK $54.90
  • Resistance Level
  • IDYA $28.41
  • FBK $60.52
  • Average True Range (ATR)
  • IDYA 0.92
  • FBK 1.08
  • MACD
  • IDYA 0.04
  • FBK 0.29
  • Stochastic Oscillator
  • IDYA 59.24
  • FBK 78.39

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

Share on Social Networks: